Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases.

Saved in:
Bibliographic Details
Title: Aberrant receptor tyrosine kinase signaling in lipofibromatosis: a clinicopathological and molecular genetic study of 20 cases.
Authors: Al-Ibraheemi A; Department of Pathology, Boston Childrens Hospital, Boston, MA, USA., Folpe AL; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Perez-Atayde AR; Department of Pathology, Boston Childrens Hospital, Boston, MA, USA., Perry K; Department of Pathology and Laboratory Medicine and Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI, USA., Hofvander J; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Arbajian E; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Magnusson L; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Nilsson J; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden., Mertens F; Division of Clinical Genetics, Department of Laboratory Medicine, Lund University, Lund, Sweden. fredrik.mertens@med.lu.se.; Division of Laboratory Medicine, Department of Clinical Genetics and Pathology, SUS Lund, Lund, Sweden. fredrik.mertens@med.lu.se.
Source: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2019 Mar; Vol. 32 (3), pp. 423-434. Date of Electronic Publication: 2018 Oct 11.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Inc Country of Publication: United States NLM ID: 8806605 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1530-0285 (Electronic) Linking ISSN: 08933952 NLM ISO Abbreviation: Mod Pathol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1530-0285
DOI:10.1038/s41379-018-0150-3